GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Melodiol Global Health Ltd (OTCPK:COPHD) » Definitions » Price-to-Free-Cash-Flow

Melodiol Global Health (Melodiol Global Health) Price-to-Free-Cash-Flow : N/A (As of Jun. 21, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Melodiol Global Health Price-to-Free-Cash-Flow?

As of today (2024-06-21), Melodiol Global Health's share price is $0.117. Melodiol Global Health's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.40. Hence, Melodiol Global Health's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Melodiol Global Health's Price-to-Free-Cash-Flow or its related term are showing as below:

COPHD's Price-to-Free-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 22.665
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Melodiol Global Health's Free Cash Flow per Share for the six months ended in Dec. 2023 was $-0.29. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-1.40.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 51.80% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 51.80% per year.

During the past 8 years, Melodiol Global Health's highest 3-Year average Free Cash Flow per Share Growth Rate was 51.80% per year. The lowest was -5.10% per year. And the median was 46.90% per year.


Melodiol Global Health Price-to-Free-Cash-Flow Historical Data

The historical data trend for Melodiol Global Health's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Melodiol Global Health Price-to-Free-Cash-Flow Chart

Melodiol Global Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - - - -

Melodiol Global Health Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Melodiol Global Health's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Melodiol Global Health's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Melodiol Global Health's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Melodiol Global Health's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Melodiol Global Health's Price-to-Free-Cash-Flow falls into.



Melodiol Global Health Price-to-Free-Cash-Flow Calculation

Melodiol Global Health's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.117/-1.397
=N/A

Melodiol Global Health's Share Price of today is $0.117.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Melodiol Global Health's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.40.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Melodiol Global Health  (OTCPK:COPHD) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Melodiol Global Health Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Melodiol Global Health's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Melodiol Global Health (Melodiol Global Health) Business Description

Traded in Other Exchanges
Address
145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009
Melodiol Global Health Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its brands include Mernova: A licensed producer of cannabis products in Canada for sale under the Ritual brand banner. Sierra Sage Herbs: US-based developer of plant-based, beauty, and personal care brands Green Goo, Southern Butter, and Good Goo. impACTIVE: CBD topical products for athletes. Halucenex: Clinical stage psychedelics research and development operation. Creso Pharma Switzerland: CBD-related research, development, and commercialization.

Melodiol Global Health (Melodiol Global Health) Headlines

From GuruFocus

Sierra Sage Herbs Acquired By Creso Pharma

By PRNewswire PRNewswire 02-07-2022